Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting - DREAM GLP-1

NCT02236299 is registered in ClinicalTrials.gov with Papworth Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02236299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02236299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting - DREAM GLP-1
Lead sponsor
Papworth Hospital NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2014
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

right coronary artery percutaneous coronary intervention, right ventricular diastolic dysfunction